Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006

January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p122
Academic Journal
The article discusses a study by Mats Fridell and colleagues conducted to identify predictors of increased risk of drug related death and non drug related death in substance abusers of opiates, stimulants, cannabis, sedatives/ hypnotics, hallucinogens and alcohol. The cohort analysis indicates that drug abusers had an increased risk of premature death to the age of 69. The drug related deaths were found significantly higher in opiate and barbiturate abusers.


Related Articles

  • Prevalence of substance use among college students in Eldoret, western Kenya. Atwoli, Lukoye; Mungla, Prisca A.; Ndung'u, Moses N.; Kinoti, Kiende C.; Ogot, Evans M. // BMC Psychiatry;2011, Vol. 11 Issue 1, p34 

    Background: Substance use among college and university students predicts substance related problems in later life. Few studies on this phenomenon have been carried out in low income countries, and most focus on primary and secondary school students. This study therefore aimed to establish the...

  • Substance-Related Disorders.  // Current Medical Literature: Psychiatry;2007, Vol. 18 Issue 4, p130 

    The article discusses several studies on substance-related disorders. A study presents representative findings on the prevalence, correlates psychiatric comorbidity and treatment of DSM-IV alcohol abuse and dependence. One study attempted to quantify the rate of reduced substance use...

  • Dual Treatment Improves Substance Abuse Recovery.  // Psychiatric Annals;Jun2005, Vol. 35 Issue 6, p470 

    Discusses a study published in the "Alcoholism: Clinical and Experimental Research" in 2005, which revealed that the treatment of comorbid mental health conditions may help adolescents recover more quickly from substance abuse disorders. Age range of patients included in the research;...

  • Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study. Paparrigopoulos, Thomas; Tzavellas, Elias; Karaiskos, Dimitris; Kourlaba, Georgia; Liappas, Ioannis // BMC Psychiatry;2011, Vol. 11 Issue 1, p41 

    Background: GABAergic anticonvulsants have been recommended for the treatment of alcohol dependence and the prevention of relapse. Several studies have demonstrated topiramate's efficacy in improving drinking behaviour and maintaining abstinence. The objective of the present open-label...

  • Depression, anxiety, and history of substance abuse among Norwegian inmates in preventive detention: Reasons to worry? Værøy, Henning // BMC Psychiatry;2011, Vol. 11 Issue 1, p40 

    Background: Inmates on preventive detention are a small and select group sentenced to an indefinite term of imprisonment. Mood disorders and substance abuse are risk factors for inmate violence and recidivism, so the prevalence of depression, anxiety, and substance abuse was examined in this...

  • Social exclusion in clients with comorbid mental health and substance misuse problems. Todd, J.; Green, G.; Harrison, M.; Ikuesan, B. A.; Self, C.; Pevalin, D. J.; Baldacchino, A. // Social Psychiatry & Psychiatric Epidemiology;Jul2004, Vol. 39 Issue 7, p581 

    Background:. The concept of comorbid mental health problems and substance misuse has gained prominence in the last two decades, due in part to the closure of large psychiatric hospitals and to the increasing prevalence of drug use in the community. This client group has a dual requirement for...

  • Lifetime psychiatric comorbidity with substance use disorders: does healthcare use modify the strength of associations ? Encrenaz, Gaelle; Messiah, Antoine // Social Psychiatry & Psychiatric Epidemiology;May2006, Vol. 41 Issue 5, p378 

    Background: The frequent psychiatric comorbidity among subjects with a substance use disorder (SUD) can be explained by an increased vulnerability to problematic drug use among subjects with a non-substance-related psychiatric disorder (NSRPD). The care of this disorder should then...

  • Psychiatric comorbidities of episodic and chronic migraine. Buse, Dawn; Silberstein, Stephen; Manack, Aubrey; Papapetropoulos, Spyros; Lipton, Richard // Journal of Neurology;Aug2013, Vol. 260 Issue 8, p1960 

    Migraine is a prevalent disabling neurological disorder associated with a wide range of medical and psychiatric comorbidities. Population- and clinic-based studies suggest that psychiatric comorbidities, particularly mood and anxiety disorders, are more common among persons with chronic migraine...

  • Cigarette Smoking. Bergen, Andrew W.; Caporaso, Neil // JNCI: Journal of the National Cancer Institute;08/18/99, Vol. 91 Issue 16, p1365 

    Describes demographic, psychosocial and biologic factors found to show associations with cigarette smoking. Details on nicotine addiction; Genetic factors associated with smoking; Association with psychiatric comorbidity and substance use.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics